 "India Glycols soars 19% as FPI buys stake, Ind-Ra upgrades credit ratings")
Shares of India Glycols (IGL) soared 19 per cent to Rs 999 on the National Stock Exchange (NSE) in Monday’s intra-day trade after the foreign portfolio investor (FPI) bought stake in the company via open market. Further, credit rating agency, India Ratings & Research (Ind-Ra), has also upgraded the company's long-term issuer ratings to 'IND A/Stable' from 'IND A-/Stable' while resolving the Rating Watch Positive (RWP).
The stock of commodity chemicals was trading at its record high level. In past one week, it has rallied 30 per cent, as against a 1.3 per cent rise in the Nifty50 index. At 10:15 am; the stock was trading 17 per cent higher at Rs 986, as against a 0.98 per cent gain in the benchmark index.
On Friday, October 1, 2021, WHV-EAM International Small Cap Equity Fund purchased 186,947 equity shares or 0.60 per cent stake of IGL at price of Rs 830.22 on the NSE via bulk deal, the exchange data shows. The name of the seller not ascertained immediately.
IGL divested 51 per cent of its stake through the issuance of subscription share in its previously wholly-owned subsidiary Clariant IGL Specialty Chemicals Private Limited (CISCPT) to Switzerland-based Clariant International Limited (Clariant), which resulted in CISCPT becoming a joint venture (JV) in the ratio of 51:49.
As per the JV agreement, IGL has transferred its bio-ethylene oxide derivatives (bio-EOD) business, to CISCPT and Clariant has infused INR5.88 billion in CISCPT as a consideration for the same. Out of the total consideration received, CISCPT has paid Rs 450 crore to IGL upfront and the balance is held in the CISCPT as 10 per cent interest-bearing shareholders loan, which will be repayable to IGL in three years.
With a significant reduction in debt; recovery in demand in chemical segments and the limited impact of divestment on profits on account of income streams from the JV, Ind-Ra expects IGL’s credit metrics to improve over the near-term, despite the company’s ongoing capex of around Rs 320 crore over FY22-FY23 to set up two grain-based distilleries, Ind-Ra said in rating rationale. CLICK HERE FOR FULL DETAILS
The stock of commodity chemicals was trading at its record high level. In past one week, it has rallied 30 per cent, as against a 1.3 per cent rise in the Nifty50 index. At 10:15 am; the stock was trading 17 per cent higher at Rs 986, as against a 0.98 per cent gain in the benchmark index.
On Friday, October 1, 2021, WHV-EAM International Small Cap Equity Fund purchased 186,947 equity shares or 0.60 per cent stake of IGL at price of Rs 830.22 on the NSE via bulk deal, the exchange data shows. The name of the seller not ascertained immediately.
IGL divested 51 per cent of its stake through the issuance of subscription share in its previously wholly-owned subsidiary Clariant IGL Specialty Chemicals Private Limited (CISCPT) to Switzerland-based Clariant International Limited (Clariant), which resulted in CISCPT becoming a joint venture (JV) in the ratio of 51:49.
As per the JV agreement, IGL has transferred its bio-ethylene oxide derivatives (bio-EOD) business, to CISCPT and Clariant has infused INR5.88 billion in CISCPT as a consideration for the same. Out of the total consideration received, CISCPT has paid Rs 450 crore to IGL upfront and the balance is held in the CISCPT as 10 per cent interest-bearing shareholders loan, which will be repayable to IGL in three years.
With a significant reduction in debt; recovery in demand in chemical segments and the limited impact of divestment on profits on account of income streams from the JV, Ind-Ra expects IGL’s credit metrics to improve over the near-term, despite the company’s ongoing capex of around Rs 320 crore over FY22-FY23 to set up two grain-based distilleries, Ind-Ra said in rating rationale. CLICK HERE FOR FULL DETAILS
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%